Mélatonine : aspects physiologiques et pharmacologiques en relation avec le sommeil, intérêt d’une forme galénique à libération prolongée (Circadin®) dans l’insomnie
Authors:
- 1 December 2018
- journal article
- review article
- Published by Elsevier in L'Encéphale
- Vol. 44 (6) , 548-557
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription databaseExpert Opinion on Pharmacotherapy, 2011
- International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin ReceptorsPharmacological Reviews, 2010
- Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safetyBMC Medicine, 2010
- Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomesCurrent Medical Research and Opinion, 2007
- Effect of Caffeine Intake 12 or 24 Hours Prior to Melatonin Intake and CYP1A2*1F Polymorphism on CYP1A2 Phenotyping by MelatoninBasic & Clinical Pharmacology & Toxicology, 2006
- The basic physiology and pathophysiology of melatoninSleep Medicine Reviews, 2005
- The anatomy and innervation of the mammalian pineal glandCell and tissue research, 2002
- Daytime melatonin administration enhances sleepiness and theta/alpha activity in the waking EEGNeuroscience Letters, 1996
- Light Suppresses Melatonin Secretion in HumansScience, 1980
- ISOLATION OF MELATONIN, THE PINEAL GLAND FACTOR THAT LIGHTENS MELANOCYTES1Journal of the American Chemical Society, 1958